A detailed history of Cambridge Trust CO transactions in Illumina, Inc. stock. As of the latest transaction made, Cambridge Trust CO holds 158 shares of ILMN stock, worth $21,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158
Holding current value
$21,644
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024

BUY
$127.73 - $147.2 $20,181 - $23,257
158 New
158 $21,000
Q3 2023

Oct 26, 2023

BUY
$128.91 - $192.44 $5,285 - $7,890
41 New
41 $5,000
Q3 2022

Nov 07, 2022

BUY
$177.23 - $227.44 $886 - $1,137
5 New
5 $1,000
Q2 2022

Aug 16, 2022

SELL
$181.58 - $368.0 $1,452 - $2,944
-8 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$303.87 - $423.8 $23,397 - $32,632
-77 Reduced 90.59%
8 $3,000
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $29,518 - $35,855
85 New
85 $32,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.